North Shore Hematology Oncology Associates P.C dba New York Cancer and Blood Specialists
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, North Shore Hematology Oncology Associates P.C dba New York Cancer and Blood Specialists sits in the upper half of US sponsors by registered trial count (#7,390 of 15,751 sponsors by registered trial count).
North Shore Hematology Oncology Associates P.C dba New York Cancer and Blood Specialists: 1 sponsored US clinical trial, 1 recruiting.
North Shore Hematology Oncology Associates P.C dba New York Cancer and Blood Specialists sponsors 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting.
Mid-pack sponsor footprint
North Shore Hematology Oncology Associates P.C dba New York Cancer and Blood Specialists is in the upper half of sponsors by trial count (#7,390 of 15,751 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.
What is open in the North Shore Hematology Oncology Associates P.C dba New York Cancer and Blood Specialists pipeline
1 recruiting of 1 indexed (100% open).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Therapeutic area indexing for this sponsor is limited in the public registry.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.